← Back to Patent Explorer
US4221793A Expired / Lapsed US ⏱️ 0.0 years remaining

N,N'-Disubstituted piperazine derivative

Assignee: Hoechst AG
•
Filing: 1978-12-21
•
Granted: 1980-09-09
•
Expires: 1998-12-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A compound of the formula ##STR1## or its acid addition salt with a physiologically compatible acid, a process for its preparation by a reaction selected from the group consisting of (a) reacting N-benzyl-piperazine and 5-methoxycumarilic acid (a1) at an elevated temperature in the absence of a condensation agent, (a2) at a temperature of at least 15° C. in the presence of a condensation agent; (b) reacting N-benzyl-piperazine with an activated derivative of 5-methoxy-cumarilic acid; (c) N-(5-methoxycumaroyl)-piperazine with a benzyl compound selected from the group consisting of benzyl halide, benzylalkyl sulfonate and benzyl-aryl sulfonate and a pharmaceutical composition containing said compounds.

Inventors

  • 👤 Rolf-Ortwin Weber
  • 👤 Klaus Perrey
  • 👤 Wolfrad von Rechenberg

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 11:14
CPC Classifications
C; C07; C07D; C07D307/00; C07D307/77; C07D307/78; C07D307/82; C07D307/84; C07D307/85; A; A61; A61P; A61P25/00; A61P25/24; A61P25/26

Claims Analysis

Total Claims: 3
Claim 1
Independent Claim 16 words
A compound of the formula ##STR3## or its acid addition salt with a physiologically compatible acid.
Claim 2
Dependent Claim 16 words
A compound of the formula ##STR3## or its acid addition salt with a physiologically compatible acid.
Claim 3
Dependent Claim 48 words
A composition containing as an essential ingredient a therapeutically active amount of a compound as claimed in claim 1 wherein the therapeutically active amount of the compound as claimed in claim 1 is in the form of a dosage unit in an amount between 10 and 100 mg.

References Cited (Backward Citations)

US4115569A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-09-09 1984-03-10 1984-09-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-09-09 1988-03-10 1988-09-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-09-09 1992-03-10 1992-09-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag